tiprankstipranks
Trending News
More News >
Prelude Therapeutics Reports 2024 Financial Results
PremiumCompany AnnouncementsPrelude Therapeutics Reports 2024 Financial Results
3M ago
Prelude Therapeutics Reports 2024 Financial Results and Updates
Premium
Company Announcements
Prelude Therapeutics Reports 2024 Financial Results and Updates
3M ago
Prelude Therapeutics reports FY24 EPS ($1.68), consensus ($1.77)
Premium
The Fly
Prelude Therapeutics reports FY24 EPS ($1.68), consensus ($1.77)
3M ago
Prelude Therapeutics presents first interim data from trial of PRT2527
PremiumThe FlyPrelude Therapeutics presents first interim data from trial of PRT2527
6M ago
Prelude Therapeutics price target lowered to $4 from $7 at JMP Securities
Premium
The Fly
Prelude Therapeutics price target lowered to $4 from $7 at JMP Securities
6M ago
Prelude Therapeutics Reports Progress in Clinical Trials and Financial Health
Premium
Company Announcements
Prelude Therapeutics Reports Progress in Clinical Trials and Financial Health
6M ago
Prelude announces publication of abstracts on SMARCA Degrader Programs
PremiumThe FlyPrelude announces publication of abstracts on SMARCA Degrader Programs
8M ago
Playtika to acquire SuperPlay, Intel says not selling Mobileye: Morning Buzz
Premium
The Fly
Playtika to acquire SuperPlay, Intel says not selling Mobileye: Morning Buzz
9M ago
Five Below downgraded, DoorDash upgraded: Wall Street’s top analyst calls
Premium
The Fly
Five Below downgraded, DoorDash upgraded: Wall Street’s top analyst calls
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100